All terms in EFO
| Label | Id | Description |
|---|---|---|
| iPS-NIHi11 | EFO_0007952 | [Induced pluripotent stem cell line isolated from skin sample AG20443.] |
| oculomucocutaneous syndrome | EFO_0020917 | [Oculomucocutaneous syndrome is characterized by keratoconjunctivitis sicca (dry eyes) and the resulting scarring, fibrosis, metaplasia, and shrinkage of the conjunctiva.] |
| hFib2-iPS4 | EFO_0007951 | [This induced pluripotent stem cell (iPSC) line was generated from dermal fibroblasts, by viral transduction of OCT4, SOX2, KLF4, c-MYC, hTERT, and SV40 Large T antigen transgenes. Cells express pluripotent markers and have a normal karyotype, 46XY.] |
| X-linked intellectual disability, Vitale type | Orphanet_85289 | |
| obsolete_omphalocele syndrome, Shprintzen-Goldberg type | Orphanet_3164 | |
| non-allergic anaphylaxis | EFO_0020918 | [Anaphylactoid reaction or non-allergic anaphylaxis are immediate systemic reactions that mimic anaphylaxis but are not caused by IgE-mediated immune responses.] |
| GM23338 | EFO_0007950 | [Induced pluripotent stem cell line; Participant #1 (hu43860C) in the Personal Genome Project: http://www.personalgenomes.org Fibroblast culture from this same subject from which this cell line was made is GM23248and a matching lymphoblast line from this same subject is GM20431.] |
| inborn disorder of gamma-aminobutyric acid metabolism | MONDO_0019224 | [An acquired metabolic disease that is has its basis in the disruption of gamma-aminobutyric acid metabolic process.] |
| obsolete_SHORT syndrome | Orphanet_3163 | |
| subacute myelo-opticoneuropathy | EFO_0020919 | [Subacute myelo-optico-neuropathy (SMON) is a neuro-degenerative disorder caused by poisoning due to over-dose and prolonged oral administration of clioquinol. This was shown by an epidemiological study in Japan in 1971, and confirmed by a series of animal experiments. It is characterized by symptoms of severe myelo-neuropathy: painful dysesthesia and paresthesia (such as tingling, stinging, fastening, cold, and sticking sensations) initiating in and moving upwards from the feet, loss of sensations, gait disturbance with ataxic and spastic paraplegia, autonomic disorders, and visual impairment, which almost invariably followed a severe abdominal pain (and sometimes led to loss of consciousness and opisthotonus), constipation, and diarrhea.] |
| X-linked intellectual disability - spastic quadriparesis | Orphanet_163982 | |
| decreased kidney function | EFO_0020912 | [Reduced ability of the kidney to perform its functions.] |
| monocyte:lymphocyte ratio | EFO_0007956 | [quantification of the ratio between absolute monocyte count and absolute lymphocyte count] |
| sarcosinemia | MONDO_0010008 | [Sarcosinemia is a metabolic disorder characterized by an increased concentration of sarcosine in plasma and urine due to sarcosine dehydrogenase deficiency.] |
| glycine metabolism disease | MONDO_0045020 | [A disease that has its basis in the disruption of glycine metabolic process.] |
| inborn disorder of serine family metabolism | MONDO_0019239 | [An acquired metabolic disease that is has its basis in the disruption of serine family amino acid metabolic process.] |
| electrocardiogram repolarisation abnormality | EFO_0020913 | [Indicates a measured cardiac repolarisation outside of the reference range.] |
| mouth morphology measurement | EFO_0007955 | [quantification of some aspect of mouth morphology such as mouth width] |
| microbrachycephaly-ptosis-cleft lip syndrome | MONDO_0010007 | [Microbrachycephaly-ptosis-cleft lip syndrome is characterised by the association of intellectual deficit, microbrachycephaly, hypotelorism, palpebral ptosis, a thin/long face, cleft lip, and anomalies of the lumbar vertebra, sacrum and pelvis. It has been described in two Brazilian sisters. Transmission appears to be autosomal recessive.] |
| disorientation | EFO_0020914 | [Inability to correctly acknowledge the current time, place, one's role, and personal identity.] |